EvoLife Launches in the US the First & Only Innovative Product Line to Help Nearly 15 Million Cancer Patients

Wednesday, March 31, 2010 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

KENDALL PARK, N.J., March 30 EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, announced the launch of its products in USA. EvoLife products from France offer doctors, nurses and caregivers around the world an effective, uniquely designed and well-tested product line that could provide relief from certain symptoms including dry skin and nail deterioration that are common before, during, and after chemotherapy/radiotherapy treatment. "EvoLife is very excited about launching cancer care products in the US to assist patients and help them feel better, like we have done in Europe and other parts of the world," said Richard Worm, CEO, EvoLife Laboratories. Quality of life among cancer patients and lack of products to address these problems continues to be serious challenge for patients and caregivers involved with treatment. The quality of life improvement among cancer patients is becoming a priority for key stakeholders, including the patient's family, who are involved with cancer treatment, particularly efforts to improve their daily life and increase ability to undergo and stay on their treatment regimen.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100330/NY79004LOGO )

Patient & Caregiver Feedback

EvoLife products are utilized at leading oncology centers around the world and have been successfully launched in 15 European countries over the last 12 months. Shilpa Sharan, PhD, MS, Vice President, Scientific & Regulatory Affairs at EvoLife said it is rewarding to hear feedback from patients like Cecilia (TX, USA), "I have used EvoNail a month now and can tell a big difference in my nails. They are much better. EvoNail soothes them and are not as sore as before. The nails are growing out now instead of getting worse as before I started using EvoNail. I'm very pleased with this product. Thank you."

In addition, caregivers have reported positive results. Johanna, (Nurse from London, UK) writes, "EvoSkin has been very effective. I have been giving this to patients receiving head and neck radiation, and they tend to suffer from the worst skin reactions. The patients prefer it to standard aqueous we usually give them at the beginning of treatment. The EvoDeo, an alcohol/metal free deodorant spray, is a big relief for breast cancer patients. Thank you for your ongoing support and help."

EvoLife products can become an integral part of managing patients while they undergo therapy and will continue to support the efforts of dermatologists, oncologists, radiologists and oncology/radiology nurses who are involved with cancer patient care.

About EvoLife Laboratories

EvoLife Laboratories, headquartered in France, has been engaged in research and development of skin care products for nearly a decade. At EvoLife Laboratories, our researchers, with years of experience in Oncology and Dermatology and over a decade of research on Chemo/radiotherapy related side effects, have developed a full range of innovative mineral products to assist cancer patients for skin, nail, hair, oral and hygiene care. EvoLife products hydrate, protect, and soothe.

In 2008, EvoLife obtained the label Cancer Bio-Health for its research and innovations in the field of cancer. This label promotes the scientific discovery of Evaux-les-Bains thermal water. At EvoLife, we are committed and dedicated to assisting cancer patients, caregivers and providers with our high quality innovative products.

For more information or questions, call 877-318-1037, email service@myevolife.com or visit www.myevolife.com

Contact: P. O. Box 5042 Kendall Park, NJ 08824-5042 Phone 877-318-1037 Fax 877-318-3377 Email service@myevolife.com www.myevolife.com

SOURCE EvoLife Laboratories

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store